ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
Ontology highlight
ABSTRACT: ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
PROVIDER: PRJNA521712 | ENA |
REPOSITORIES: ENA
ACCESS DATA